5-methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione

Catalog No. :
ACFZCD621
CAS No. :
91105-97-4
Molecular Formula :
C10H9NO4
Molecular Weight :
207.18

IUPAC Name:5-methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione

5-methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$179.00Login to see priceIn stockInquiry
1g95%$357.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione
IUPAC Name5-methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione
Molecular FormulaC10H9NO4
Molecular Weight207.18
SMILESCOC1=C2C(=O)OC(=O)N(C)C2=CC=C1
InChI KeySBDOXZYEPLBJEK-UHFFFAOYSA-N
Synonym2H-3,1-Benzoxazine-2,4(1H)-dione, 5-Methoxy-1-Methyl-;5-methoxy-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione;5-Methoxy-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione;8-Methoxy-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione;3-METHOXY-N-METHYLISATOIC ANHYDRIDE
CAS No.91105-97-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFZCD621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGHAO432 route compound structure diagram
    ACGHAO43267765-42-8 In Stock
  4. Then
  5. ACFZCD621 route product structure diagram
    ACFZCD62191105-97-4 In Stock
Inquiry

2. ACFZCD621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZCD621 route product structure diagram
    ACFZCD62191105-97-4 In Stock
Inquiry

Comments (0)